Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion type Assertion NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_head.
- NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion description "[Seventy-two patients who received ADV in addition to LAM for breakthrough hepatitis were enrolled.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_provenance.
- NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion evidence source_evidence_literature NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_provenance.
- NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion SIO_000772 21503906 NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_provenance.
- NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion wasDerivedFrom befree-20140225 NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_provenance.
- NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_assertion wasGeneratedBy ECO_0000203 NP562723.RAVCXZw44IXDF4Ps77N-xUtCRJAhgvxo_qaK2qR7cXRyc130_provenance.